Filing Summary
Company and reporting period: SciSparc Ltd., a foreign private issuer, furnished this Form 6-K for October 2026, dated October 7, 2026.
Business context
The filing reports that SciSparc issued a press release about subsidiary NeuroThera Labs’ CliniQuantum platform. The release title describes a quantum-enabled analysis of billions of gene combinations using real-world clinical data on an S&P 500 company’s quantum architecture. The press release is identified as Exhibit 99.1, but its text is not included in the provided filing content.
Financial results and changes
This filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics, and no comparison with a prior period. It contains no financial guidance.
Other filing details
The report is incorporated by reference into the company’s listed Form F-3 and Form S-8 registration statements, subject to later filings or furnished reports. It is signed by Oz Adler, Chief Executive Officer and Chief Financial Officer.
Important facts to verify
- Review Exhibit 99.1 for the analysis’ methods, scope, results, and any limitations; those details are not provided in the supplied text.
- Verify whether the press release reports commercial progress, partnerships, costs, or other material developments; the filing excerpt does not establish these.
- Do not interpret the announcement as financial guidance or evidence of a change in SciSparc’s financial condition; no such information is provided here.